The number of patients with cancer in the trials underpinning guideline recommendations for angiotensin‐converting enzyme inhibitors, beta‐blockers and MRA in HFrEF has not been reported.17, 18, 19, 20, 21, 22. This evidence concerns the gene ACE and cancer.